ADepT for treatment of complex depressio

Not Applicable

• Conditions: Depression; Mental and Behavioural Disorders

• Registration Number: ISRCTN75828354
• Lead Sponsor: niversity of Exeter

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-21
• Last Update Posted: 6 March 2023
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Aged >18 years
2. Score in the clinical range on the PHQ-9 depression scale (scores =10)
3. Meet diagnostic criteria for a current major depressive episode using the Structured Clinical Interview for Diagnosis
4. Describe depression as the primary presenting problem they wish to work on
5. Report some difficulties in emotional, interpersonal, identity or impulsivity regulation, consistent with personality difficulties and/or mild personality disorder linked to exposure to complex trauma during childhood
6. Willing and able to give informed consent for participation in the trial
7. Have working knowledge of written and spoken English, sufficient to be able to make use of therapy and to be able complete research assessments without the need for a translator
8. Willing to allow their General Practitioner to be notified of participation in the trial

Exclusion Criteria

1. Currently receiving other psychosocial therapies
2. Presenting with another area of difficulty that the therapist and/or client believe should be the primary focus of the current intervention (for example, PTSD, complex PTSD, eating disorder)
3. reporting a current/past history of schizophrenia or bipolar disorder
4. Presenting with current moderate to severe personality disorder that requires secondary or tertiary care management
5. Displaying marked risk to self (self-harm or suicide) or others that the clinician judges could not be managed safely using weekly therapy in an out-patient setting and that would interfere with engagement in therapy
6. Presenting with features of substance misuse, problematic eating, and/or antisocial that the clinician judges could not be managed safely using weekly therapy in an out-patient setting and that would interfere with engagement in therapy
7. Presenting with features of a learning disability that the clinician judges would interfere with engagement in therapy and capacity to complete research assessments
8. Currently lacking capacity to give informed consent
9. Presenting with any other significant, severe or life-threatening disease, disorder, or cognitive impairment that the clinician judges may either put the participants at risk because of participation in the trial, may influence the result of the trial, or inhibit the participant’s ability to participate in the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified